Is Lincomycin registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Lincomycin.

Is Lincomycin approved by the US FDA?

Drugs@FDA lists 9 application product lines for Lincomycin, including LINCOCIN (Prescription); LINCOMYCIN HYDROCHLORIDE (Prescription); LINCOMYCIN HYDROCHLORIDE (Prescription); LINCOMYCIN HYDROCHLORIDE (Prescription); LINCOMYCIN HYDROCHLORIDE (Prescription).

Are there safety signals or safety updates for Lincomycin?

US FDA: 1 entry (latest 2022-04-11).

Active substance

Lincomycin

SFDA 2
US FDA 9
Safety 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
LINCOCIN CAPS. 500 MG.	500 mg	Capsule · Oral use	12 Blister	SAR 21.05	NCE · Prescription	PHARMACIA UPJOHN	Withdrawn by MAH · Not Marketed
LINCOCIN SYRUP 250 MG-5ML	50 mg/ml	Oral suspension · Oral use	1 Bottle	SAR 17.25	NCE · Prescription	PHARMACIA UPJOHN	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
LINCOCIN	EQ 300MG BASE/ML	injectable · injection	PFIZER	Prescription	29 Dec 1964
LINCOMYCIN HYDROCHLORIDE	EQ 300MG BASE/ML	injectable · injection	XGEN PHARMS	Prescription	4 Jun 2015
LINCOMYCIN HYDROCHLORIDE	EQ 300MG BASE/ML	injectable · injection	QUAGEN	Prescription	12 Mar 2021
LINCOMYCIN HYDROCHLORIDE	EQ 300MG BASE/ML	injectable · injection	MICRO LABS	Prescription	8 Nov 2021
LINCOMYCIN HYDROCHLORIDE	EQ 300MG BASE/ML	injectable · injection	GLAND	Prescription	26 Sep 2022
LINCOMYCIN HYDROCHLORIDE	EQ 300MG BASE/ML	injectable · injection	HAINAN POLY	Prescription	21 Dec 2022
LINCOCIN	EQ 250MG BASE; EQ 500MG BASE	capsule · oral	PHARMACIA AND UPJOHN	Discontinued	29 Dec 1964
LINCOMYCIN HYDROCHLORIDE	EQ 300MG BASE/ML	injectable · injection	SLAYBACK	Discontinued	16 Apr 1991
LINCOMYCIN HCL	EQ 300MG BASE/ML	injectable · injection	QUAD PHARMS	Discontinued

Safety signals and safety-related labeling changes

US FDA 11 Apr 2022 LINCOCIN — safety-related labeling change
Labeling sections changed: Boxed Warning; Warnings and Precautions; Adverse Reactions; Use in Specific Populations

All safety entries for lincomycin →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.